Note 13 - Segment Information (Tables)

6 Months Ended

Dec. 31, 2020

Notes Tables

Schedule of Segment Reporting Information, by Segment [Table Text Block]

	Quarter Ended						Six Months Ended
	December 31,						December 31,
	2020			2019			2020			2019
Net sales:
Protein Sciences	$	172,179		$	141,517		$	326,625		$	282,512
Diagnostics and Genomics		52,469			43,846			102,595			86,397
Intersegment		(395	)		(429	)		(768	)		(732	)
Consolidated net sales	$	224,253		$	184,934		$	428,452		$	368,177
Operating income:
Protein Sciences	$	80,246		$	60,872		$	150,598		$	120,410
Diagnostics and Genomics		8,107			975			16,781			1,875
Segment operating income	$	88,353		$	61,847		$	167,379		$	122,285
Costs recognized on sale of acquired inventory		(23	)		-			(23	)		-
Amortization of acquisition related intangible assets		(15,027	)		(15,108	)		(30,528	)		(30,008	)
Acquisition related expenses		(4,421	)		881			(4,558	)		(429	)
Stock based compensation		(16,225	)		(10,618	)		(29,558	)		(19,418	)
Restructure costs		(142)			-			(142	)		-
Corporate general, selling, and administrative expenses		(1,520	)		(12	)		(2,482	)		(2,113	)
Consolidated operating income	$	50,995		$	36,992		$	100,087		$	70,317